Mark Weinberg has joined Avillion LLP as chief medical officer to help manage the late-stage clinical development of pharmaceutical assets. Avillion partners with pharma to advance and make regulatory submissions for these products. Dr Weinberg joins Avillion from Halloran Consulting Group where he was CMO and managing director. He is also a former executive of Astellas Pharma Inc.
He earned an MD from Duke University, holds a Master of Business Administration from the Kellogg Business School and a BA in economics from Yale University, all in the US.
Avillion announced the appointment on 20 January 2017
Copyright 2017 Evernow Publishing Ltd